Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers

Healthcare providers are unfamiliar with LDL-C targets and how to implement therapeutic regimens to achieve treatment goals in rural patient populations.  Healthcare providers lack familiarity with the role of elevated Lp(a)...  Read More

Multiple Presenters Tyler Gluckman; Rishi Wadhera;

Opioid Prescribing & Addiction

These online modules are intended to help the prescriber identify and screen for substance use disorders, use KASPER and urine drug testing therapeutically, and recommend treatment options particularly for vulnerable populations.  Read More

Redesigned Family Medicine Review

These two 3-day conferences will feature the most up to date changes in disease state management and drug therapies for family medicine practitioners along with interactive workshops. HB1 credit and Nursing Pharmacology hours will be available.  Read More

DEA Medication Access and Training Expansion (MATE) Act

Starting June 27, 2023, renewing DEA-registered practitioners must complete 8 hours of one-time training on the treatment and management of patients with opioid or other substance use disorders  Read More

Truth or Consequences – Dispelling Vaccine Myths

The CDC has newly issued recommendations for the monovalent COVID booster targeting new strains for everyone older than 6 months of age. In addition, there are two new RSV vaccines, one for infants and one for adults....  Read More

Multiple Presenters Frank Romanelli; Alice Thornton; Kimberly Northrip; Divya Cantor; Nicholas Van Sickels;